It looks like GlaxoSmithKline's concerns about its respiratory syncytial virus (RSV) vaccine in pregnant women aren't going to be resolved quickly. After suspending three trials of the much ...
The drug was approved by the UK Medicines and Healthcare products Regulatory ... of these around 170 women could be eligible for treatment with GSK's antibody, which has also been approved in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback